P3 Health Partners Reports 9% Revenue Growth to $386.4 Million in Q2 2026

P3 Health Partners Inc. reported its financial results for the second quarter of 2026, revealing a total operating revenue of $386.4 million, a 9% increase from $355.8 million in the same period last year. The growth was primarily driven by a 4% rise in capitated revenue, which reached $366.4 million, attributed to strategic contractual restructuring and improved performance metrics. However, the average number of at-risk members decreased by 10% year-over-year, from 115,900 to 104,800, reflecting the company's ongoing efforts to rationalize its network and payer contracts.

The company achieved an operating income of $41.2 million for the quarter, a significant turnaround from an operating loss of $34.1 million in Q2 2025. This improvement was supported by a reduction in medical expenses, which fell by 15% to $300.4 million, largely due to a decrease in the number of at-risk members and favorable claims development. Corporate, general, and administrative expenses also increased by 38% to $32.4 million, driven by higher consulting costs and accrued performance bonuses.

P3 Health Partners has made notable strategic moves, including a significant debt exchange agreement with Chicago Pacific Founders, which converted approximately $252.5 million of unsecured promissory notes into preferred stock. This transaction, completed on April 27, 2026, was aimed at improving the company's balance sheet and compliance with Nasdaq listing requirements. Additionally, the company entered into a Securities Purchase Agreement to issue up to $70 million in preferred stock and warrants, with $51.3 million already sold as of June 30, 2026.

Operationally, P3 Health Partners expanded its network, serving approximately 104,400 at-risk members across 26 markets in five states. The company reported a total of 2,100 primary care physicians in its affiliate network as of June 30, 2026. Despite these advancements, P3 continues to face challenges, including a working capital deficit of $209.2 million and an accumulated deficit of $642.5 million. The company has indicated substantial doubt about its ability to continue as a going concern without raising additional capital, which it is actively pursuing through various financing options.

Looking ahead, P3 Health Partners aims to enhance its membership growth through existing contracts and new market opportunities. The company is focused on improving its capitated revenue per member and effectively managing medical expenses to achieve operational efficiencies. However, the ongoing need for capital raises and the potential impact of regulatory changes in the healthcare sector remain critical factors that could influence its future performance.